Work

Immune checkpoint inhibitors revolutionize the treatment of malignant melanoma – insights from the Cancer Registry Saxony

Year: 2025

Type: conference-paper

Abstract: Introduction: The introduction of immune checkpoint inhibitors (ICI) in 2011 symbolizes a paradigm shift in cancer treatment. Especially in metastatic malignant melanoma, the first cancer entity for which ICIs were approved [ref:1], significant better treatment results have been described. [for full text, please go to the a.m. URL]

Source: German Medical Science (German Research Foundation)

DOI: 10.3205/25gmds087

Authors: Lang, Sabine, Neubert, Maria Andrea, Schubotz, Birgit, Unger, Solveig, Selig, Jessica Isabel

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7103902506

FWCI:

Cites:

Cited by:

Related to: